Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

Completed · Phase 3 · Has a placebo group

Conditions studied: Motion Sickness

In brief

A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel

Key facts

Study ID

NCT05903924

Run by

Vanda Pharmaceuticals

People needed

316

Starts

2023-09-09

Expected to finish

2024-04-24

Last updated by the study team

2025-04-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of motion sickness
• Age 18-75

You may not qualify if…

• Nausea-inducing disorder other than motion sickness
• BMI>40
• History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists

Where it is running

• Pacific Research Partners — San Diego, California, United States
• Lumos Clinical Research — San Jose, California, United States
• Santa Monica Clinical Trials — Santa Monica, California, United States
• Beacon Clinical Research — Boston, Massachusetts, United States
• Manhattan Medical Research — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.